EPS for Allergan plc (AGN) Expected At $3.36; Last Week Viavi Solutions Inc. (VIAV) Analysts

April 21, 2018 - By Marie Mckinney

Allergan plc (NYSE:AGN) Logo

Analysts expect Allergan plc (NYSE:AGN) to report $3.36 EPS on April, 30 before the open.They anticipate $0.01 EPS change or 0.30% from last quarter’s $3.35 EPS. AGN’s profit would be $1.10B giving it 11.79 P/E if the $3.36 EPS is correct. After having $4.86 EPS previously, Allergan plc’s analysts see -30.86% EPS growth. The stock decreased 0.05% or $0.08 during the last trading session, reaching $158.51. About 3.18 million shares traded. Allergan plc (NYSE:AGN) has declined 33.03% since April 21, 2017 and is downtrending. It has underperformed by 44.58% the S&P500.

Among 7 analysts covering Viavi Solutions Inc (NASDAQ:VIAV), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Viavi Solutions Inc had 13 analyst reports since August 5, 2015 according to SRatingsIntel. The stock has “Hold” rating by Craig Hallum on Wednesday, August 12. On Thursday, August 13 the stock rating was initiated by UBS with “Buy”. The rating was reinitiated by William Blair on Friday, August 14 with “Outperform”. The rating was upgraded by JP Morgan on Tuesday, October 11 to “Overweight”. As per Wednesday, August 12, the company rating was downgraded by Craig-Hallum. RBC Capital Markets downgraded it to “Outperform” rating and $8.0 target in Monday, August 10 report. Jefferies maintained the shares of VIAV in report on Friday, August 14 with “Hold” rating. As per Monday, June 6, the company rating was maintained by M Partners. B. Riley & Co upgraded Viavi Solutions Inc. (NASDAQ:VIAV) on Wednesday, August 5 to “Buy” rating. See Viavi Solutions Inc. (NASDAQ:VIAV) latest ratings:

The stock decreased 0.30% or $0.03 during the last trading session, reaching $10.07. About 1.03 million shares traded. Viavi Solutions Inc. (NASDAQ:VIAV) has declined 11.57% since April 21, 2017 and is downtrending. It has underperformed by 23.12% the S&P500.

Viavi Solutions Inc. provides network test, monitoring, and assurance solutions to communications service providers, and enterprises and their ecosystems worldwide. The company has market cap of $2.28 billion. The firm operates through Network Enablement, Service Enablement, and Optical Security and Performance Products divisions. It has a 79.29 P/E ratio. The Network Enablement segment offers testing solutions that access the network to perform build-out and maintenance tasks.

Allergan plc, a specialty pharmaceutical company, develops, makes, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. The company has market cap of $51.93 billion. It operates through US Specialized Therapeutics, US General Medicine, and International divisions. It currently has negative earnings. The firm offers a portfolio of products that provide treatment for the central nervous system, gastroenterology, women??s health and urology, ophthalmology, neurosciences, medical aesthetics, dermatology, plastic surgery, liver disease, inflammation, metabolic syndromes, and fibrosis, as well as Alzheimer??s disease.

Viavi Solutions Inc. (NASDAQ:VIAV) Ratings Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>